Treatment of Retinoblastoma in the Transgenic Mouse

Lasudry, Jacques G.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: Fogarty International Center (FIC)
• Type: International Research Fellowships (FIC) (F05)
• Project #: 1F05TW004797-01
• Application #: 3022477
• Study Section: International and Cooperative Projects 1 Study Section (ICP)
• Project Start: 1992-09-30
• Budget Start: 1992-09-30
• Budget End: 1993-09-29
• Support Year: 1
• Fiscal Year: 1992

Institution

• Name: Harvard University
• Type: Schools of Medicine
• DUNS #: 082359691
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02115

Publications

Shternfeld, I S; Lasudry, J G; Chappell, R J et al. (1996) Antineoplastic effect of 1,25-dihydroxy-16-ene-23-yne-vitamin D3 analogue in transgenic mice with retinoblastoma. Arch Ophthalmol 114:1396-401

Albert, D M; Griep, A E; Lambert, P F et al. (1994) Transgenic models of retinoblastoma: what they tell us about its cause and treatment. Trans Am Ophthalmol Soc 92:385-400;discussion 400-1